The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Girshick Birgit since 2018.
This trader's CIK number is 1732091.
At the time of last reporting, Girshick Birgit was the Corporate Executive VP & COO of Charles River Laboratories International, Inc.. (stock ticker symbol CRL).
Also see all insider trading activities at Charles River Laboratories International, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CRL | 0 | $0 | 0 | $0 | 5,916 | $1,273,064 |
| 2023 | CRL | 1,322 | $248,298 | 3,205 | $807,336 | 3,205 | $350,434 |
| 2021 | CRL | 0 | $0 | 23,410 | $7,397,257 | 20,985 | $2,299,228 |
| 2020 | CRL | 0 | $0 | 2,613 | $483,326 | 0 | $0 |
| 2019 | CRL | 0 | $0 | 15,949 | $2,234,934 | 9,604 | $834,971 |
| 2018 | CRL | 0 | $0 | 13,871 | $1,556,298 | 7,313 | $544,511 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-10 | CRL | Option Ex | 5,916 | 215.19 | 1,273,064 |
| 2023-11-20 | CRL | Buy | 1,322 | 187.82 | 248,298 |
| 2023-02-16 | CRL | Option Ex | 3,205 | 109.34 | 350,434 |
| 2023-02-16 | CRL | Sale | 3,205 | 251.90 | 807,336 |
| 2021-09-13 | CRL | Sale | 81 | 442.18 | 35,816 |
| 2021-09-14 | CRL | Sale | 2,344 | 439.90 | 1,031,125 |
| 2021-04-06 | CRL | Sale | 18,311 | 302.57 | 5,540,304 |
| 2021-04-05 | CRL | Sale | 999 | 298.00 | 297,702 |
| 2021-04-06 | CRL | Option Ex | 18,311 | 114.02 | 2,087,820 |
| 2021-04-05 | CRL | Option Ex | 999 | 88.05 | 87,961 |
| 2021-02-19 | CRL | Option Ex | 1,675 | 73.70 | 123,447 |
| 2021-02-19 | CRL | Sale | 1,675 | 293.92 | 492,310 |
| 2020-08-20 | CRL | Sale | 933 | 213.51 | 199,204 |
| 2020-05-12 | CRL | Sale | 780 | 165.74 | 129,277 |
| 2020-02-13 | CRL | Sale | 900 | 172.05 | 154,845 |
| 2019-12-09 | CRL | Sale | 1,051 | 145.57 | 152,996 |
| 2019-12-09 | CRL | Sale | 2,420 | 144.26 | 349,106 |
| 2019-12-09 | CRL | Sale | 2,874 | 144.91 | 416,474 |
| 2019-11-13 | CRL | Option Ex | 9,604 | 86.94 | 834,971 |
| 2019-11-13 | CRL | Sale | 8,105 | 137.03 | 1,110,652 |
| 2019-11-13 | CRL | Sale | 1,499 | 137.23 | 205,706 |
| 2018-07-17 | CRL | Sale | 3,978 | 119.90 | 476,962 |
| 2018-03-06 | CRL | Option Ex | 7,313 | 74.46 | 544,511 |
| 2018-03-06 | CRL | Sale | 9,893 | 109.10 | 1,079,336 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Girshick Birgit (Corporate Executive VP & COO of Charles River Laboratories International, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.